mRNA CDMO (Contract Development and Manufacturing Organization) is an emerging industry in the biopharmaceutical field that has attracted much attention in recent years. It stems from a rapidly evolving need for gene therapy and vaccine development. After the outbreak of the new crown, the global demand for vaccines has increased significantly, and mRNA technology has proved to have great potential.

The rise of mRNA CDMO is closely related to the start of new crown vaccine development at the end of 2019. mRNA technology can use the body's own mechanism to synthesize vaccines, which is faster and more flexible than traditional technologies. However, due to the high technical threshold, complex equipment and huge capital investment, many companies do not have the ability to develop and produce mRNA vaccines on their own.

Faced with this challenge, mRNA CDMO is an effective solution. These institutions specialize in the development and manufacture of mRNA vaccines, providing a full range of services from gene synthesis and quality control analysis to clinical trials. They meet market demand by partnering with pharmaceutical companies to provide them with high-quality, efficient mRNA production platforms.

Currently, there is intense competition for mRNA CDMO companies worldwide, especially in the US and European markets. These companies have launched their own technology platforms and production facilities to meet the needs of gene therapy and vaccine research and development. At the same time, the government is also increasing its support to the mRNA CDMO industry to promote its further development.

In conclusion, the rise of mRNA CDMO is closely related to the rapid development of gene therapy and vaccine research and development. It provides a flexible and efficient solution for the biopharmaceutical field, and promotes the application and promotion of mRNA technology. With the continuous advancement of technology and the continuous expansion of the market, the mRNA CDMO industry is expected to achieve greater development.